Xiaojing Yuan, MPH

Articles by Xiaojing Yuan, MPH

Value-Based Insurance Design in Louisiana: Blue Cross Blue Shield’s Zero Dollar Co-pay Program

ByXiaojing Yuan, MPH,Janet Chaisson, BS,Dawn Cantrell, BA,Brice L. Mohundro, PharmD, BCACP,Mollie Carby, PharmD, MBA,Milam Ford, MPH,Miao Liu, MS,Jason Ouyang, MD,Yuan Zhang, PhD,Heath C. Williams, MBA,Benjamin V. Vicidomina, BS,Vindell Washington, MD, MS,Somesh C. Nigam, PhD

June 11th 2020

Enrollment in a value-based insurance design program that eliminated pharmacy co-pays for 4 chronic disease drug classes was associated with a large decline in health care spending.

Evaluation of the Quality Blue Primary Care Program on Health Outcomes

ByQian Shi, PhD, MPH,Thomas J. Yan, MS,Peter Lee, BS,Paul Murphree, MD, MHA,Xiaojing Yuan, MPH,Hui Shao, PhD, MHA,William H. Bestermann, MD,Selina Loupe, BS,Dawn Cantrell, BA,David Carmouche, MD,John Strapp, BA,Lizheng Shi, PhD, MSPharm

December 15th 2017

Implementation of the Quality Blue Primary Care program in Louisiana was associated with a shift in primary care delivery and reductions in overall cost.

Latest Updated Articles

Evaluation of the Quality Blue Primary Care Program on Health Outcomes
Published: December 15th 2017 | Updated:
Value-Based Insurance Design in Louisiana: Blue Cross Blue Shield’s Zero Dollar Co-pay Program
Published: June 11th 2020 | Updated:

Xiaojing Yuan, MPH

Articles by Xiaojing Yuan, MPH

Value-Based Insurance Design in Louisiana: Blue Cross Blue Shield’s Zero Dollar Co-pay Program

Evaluation of the Quality Blue Primary Care Program on Health Outcomes

Latest Updated Articles

Trending on AJMC

Withdrawal of Aid Could Cause Millions of Lives Lost to HIV

EASO Recommends Semaglutide, Tirzepatide for First-Line Obesity Therapy

Recent FDA Approvals Expand Dermatology Options for Patients With Skin of Color

Opportunities and Obstacles Associated With the Medicare Diabetes Prevention Program

FDA Approves Second Generic Mifepristone Pill for Abortion